Showing results (1851-1860 of 2,043) with videos related to
Sort By:
Pageof 205
Scientific Reports|December 29, 2019
The Prognostic Value of Circulating Tumor Cells in Asian Neuroendocrine TumorsJason Chia-Hsun Hsieh, Guan-Yu Chen, David Da-Wei Jhou, et al.Pediatric Blood & Cancer|May 28, 2020
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1Amy E Armstrong, Steven D Rhodes, Abbi Smith, et al.Rheumatology (Oxford, England)|May 24, 2025
Baricitinib for Takayasu arteritis refractory to TNF-α inhibitors: a multicentre, single-arm trialJiachen Li, Weiyi Xia, Huijuan Ji, et al.Medicine|June 11, 2015
Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow MetastasesWen-Chi Chou, Kun-Yun Yeh, Meng-Ting Peng, et al.Cancer Chemotherapy and Pharmacology|March 26, 2009
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancerHui-Ju Ch'ang, Chin-Lun Huang, Hsiu-Po Wang, et al.The Oncologist|November 20, 2024
Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancerWen-Kuan Huang, Yan-Jei Tang, Chiao-En Wu, et al.Journal of Surgical Oncology|July 19, 2019
Postoperative dynamic survival of gastric cancer patients: A multi-institutional, international analysis of 22 265 patientsJia-Bin Wang, Qing Zhong, Wei Wang, et al.Journal of Hazardous Materials|August 16, 2021
Di (2-ethyl-hexyl) phthalate disrupts placental growth in a dual blocking modeCong-Cong Sun, Shuai Zhao, Ling-Luo Chu, et al.Asia-Pacific Journal of Clinical Oncology|May 23, 2022
Safety and effectiveness of transdermal buprenorphine in cancer pain: An observational study in Taiwan (SOOTHE)Tai-Lin Huang, Yen-Min Huang, Min-Mo Hou, et al.The Journal of Clinical Investigation|September 19, 2018
Chromatin regulator Asxl1 loss and Nf1 haploinsufficiency cooperate to accelerate myeloid malignancyPeng Zhang, Fuhong He, Jie Bai, et al.Pageof 205